Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
Main Authors: | Abdul Aziz, Mohd. Hafiz, Lipman, Jeffrey, Akova, Murat, Bassetti, Matteo, De Waele, Jan J., Dimopoulos, George, Dulhunty, Joel M., Kaukonen, Kirsi-Maija, Koulenti, Despoina, Martin, Claude, Montravers, Philippe, Rello, Jordi, Rhodes, Andrew, Starr, Therese, Wallis, Steven C., Roberts, Jason A. |
---|---|
Format: | Article |
Language: | English |
Published: |
Oxford University Press
2015
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/44981/ http://irep.iium.edu.my/44981/ http://irep.iium.edu.my/44981/ http://irep.iium.edu.my/44981/1/J._Antimicrob._Chemother.-2015-Abdul-Aziz-jac-dkv288.pdf |
Similar Items
-
The DALI study: defining antibiotic levels in intensive care unit patients: prolonged infusion of beta-lactam antibiotics in critically ill patients
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2013) -
What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?
by: Alobaid, Abdulaziz S., et al.
Published: (2015) -
Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project.
by: Delgado-Valverde, Mercedes, et al.
Published: (2016) -
Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis
by: Rhodes, Nathaniel J., et al.
Published: (2018) -
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
by: Abd. Rahman, Nurul Azrin, et al.
Published: (2013)